Effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on serum interleukin-1 β, osteocalcin, and C-reactive protein levels in rats

Journal of Periodontology

Volumn 77, Issue 4, 2006, Pages 657-663

  Vardar Şengül, Saynur ^a   Buduneli, Nurcan ^a   Buduneli, Eralp ^a   Baylas, Haluk ^a   Atilla, Gül ^a   Lappin, David ^b   Kinane, Denis F ^c  

^a EGE UNIVERSITY   (Turkey)

^b GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

C reactive protein; Celecoxib; Interleukin 1 beta; Omega 3 fatty acid; Osteocalcin; Serum

Indexed keywords

C REACTIVE PROTEIN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; OMEGA 3 FATTY ACID; OSTEOCALCIN; SODIUM CHLORIDE; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; INTERLEUKIN 1; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BONE REMODELING; CELL ACTIVITY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERIODONTITIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; RAT STRAIN; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; NONPARAMETRIC TEST; SPRAGUE DAWLEY RAT;

ALVEOLAR BONE LOSS; ANIMALS; C-REACTIVE PROTEIN; CYCLOOXYGENASE 2 INHIBITORS; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, OMEGA-3; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; OSTEOCALCIN; PERIODONTITIS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; SULFONAMIDES;

EID: 33646934387     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050164     Document Type: Article

References (39)

1. Offenbacher S, Soskolne WA, Collins JG. Prostaglandins and other eicosanoids in gingival crevicular fluid as markers of periodontal disease activity. In: Johnson NW, ed. Risk Markers for Oral Diseases, Vol. 3: Periodontal Disease. London: Cambridge University Press; 1991:313-338.
2. Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 1999;106:37S-42S.
3. Lefkowith JB. Cyclooxygenase-2 specificity and its clinical implications. Am J Med 1999;106:43S-50S.
4. Zhang F, Engebretson SP, Morton RS, Cavanaugh PF Jr., Subbaramaiah K, Dannenberg AJ. The overexpression of cyclooxygenase-2 in chronic periodontitis. J Am Dent Assoc 2003;134:861-867.
5. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
6. 2α upregulates interleukin-6 production in human gingival fibroblasts. J Periodontal Res 2001;36:80-87.
7. 2α in human gingival fibroblasts. J Periodontal Res 2001;36:334-339.
8. Bezerra MM, Lima V, Alencar VBM, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009-1014.
9. Holzhausen M, Rossa C Jr., Marcantonio E Jr., Nassar PO, Spolidorio DMP, Spolidorio LC. Effect of selective cyclooxygenase-2 inhibition on development of ligature-induced periodontitis in rats. J Periodontol 2002;73:1030-1036.
10. Li Y, Seifert MF, Ney DM, et al. Dietary conjugated linoleic acids alter serum IGF-1 and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 1999;14:1153-1162.
11. Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF. Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 2000;130:2274-2284.
12. Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging 1998;10:385-394.
13. Rosenstein ED, Kushner LJ, Kramer N, Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids 2003;68:213-218.
14. Lian JB, Gundberg CM. Osteocalcin: Biochemical considerations and clinical applications. Clin Orthop Relat Res 1988;226:267-291.
15. Christenson RH. Biochemical markers of bone metabolism: An overview. Clin Biochem 1997;30:573-593.
16. Giannobile WV. Crevicular fluid biomarkers of oral bone loss. Curr Opin Periodontol 1997;4:11-20.
17. Shibutani T, Inuduka A, Horiki I, Luan Q, Iwayama Y. Bisphosphonate inhibits alveolar bone resorption in experimentally-induced peri-implantitis in dogs. Clin Oral Implants Res 2001;12:109-114.
18. Shi F, Yu S, Xu L. Analysis of serum osteocalcin of patients with periodontitis. Zhonghua Kou Qiang Yi Xue Za Zhi 1996;31:300-302.
19. Ebersole JL, Capelli D. Acute-phase reactants in infections and inflammatory diseases. Periodontol 2000 2000;23:19-49.
20. Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107:347-352.
21. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71: 1528-1534.
22. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT. Periodontal disease and risk of cerebrovascular disease. Arch Intern Med 2000;160:2749-2755.
23. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
24. Vardar S, Buduneli E, Baylas H, Hüseyinov Berdeli A, Buduneli N, Atilla G. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. J Periodontol 2005;76:99-106.
25. Chang KM, Ryan ME, Golub LM, Ramamurthy NS, McNamara TF. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: Effect of minocycline therapy. Res Commun Mol Pathol Pharmacol 1996;91: 303-318.
26. Ramamurthy NS, Golub LM, Gwinnett AJ, Salo T, Ding Y, Sorsa T. In vivo and in vitro inhibition of metalloproteinases including MMP-13 by several chemically modified tetracyclines (CMTs). In: Davidovitch D, Mah J, eds. Biologic Mechanisms of Tooth Eruption, Resorption and Replacement by Implants. Boston: Harvard Society for the Advancement of Orthodontics; 1998:271-277.
27. Morton RS, Dongari-Bagtzoglou AI. Cyclooxygenase-2 is upregulated in inflamed gingival tissues. J Periodontol 2001;72:461-469.
28. Ohm K, Albers HK, Lisboa BP. Measurement of eight prostaglandins in human gingival and periodontal disease using high pressure liquid chromatography and radioimmunoassay. J Periodontal Res 1984;19: 501-511.
29. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid MMP-8 levels following adjunctive use of meloxicam and initial phase of periodontal treatment. J Periodontol 2002; 73:103-109.
30. 4 levels in gingiva and submandibular salivary glands of rats fed diet containing n-3 fatty acids. Lipids 1991;26:895-900.
31. Campan P, Planchand P-O, Duran D. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. J Clin Periodontol 1997; 24:907-913.
32. Hotz G. Treatment of postoperative and posttraumatic edema by medicines (in German). ZWR 1986;95: 256-261.
33. Croft KD, Sturm MJ, Codde JP, Vandongen R, Beilin LJ. Dietary fish oils reduce plasma levels of platelet activating factor precursor (lyso-PAF) in rats. Life Sci 1986; 38:1875-1882.
34. Paschos GK, Rallidis LS, Liakos GK, et al. Background diet influences the anti-inflammatory effect of alpha-linolenic acid in dyslipidemic subjects. Br J Nutr 2004; 92:649-655.
35. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;34:1806-1811.
36. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003;35:772-781.
37. 2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo. Photochem Photobiol 2004;80:231-235.
38. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 2003; 30:334-340.
39. Geelen A, Brouwer IA, Schouten EG, Kluft C, Katan MB, Zock PL. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr 2004;58:1440-1442.